Dynamics of complete responses (CRs) in patients with relapsed or refractory follicular lymphoma (R/R FL) treated with odronextamab in the ELM-2 study.

Luminari S, Jiménez-Ubieto A, Chong G, Tucker D, Ambati S, Lin C, Mohamed H, Brouwer-Visser J, Otele CA, Antico G, Villasboas JC

Open source

DOI
10.1002/hem3.70300
Published
2026 Apr
Container
HemaSphere
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hem3.70300,
  title = {Dynamics of complete responses (CRs) in patients with relapsed or refractory follicular lymphoma (R/R FL) treated with odronextamab in the ELM-2 study.},
  author = {Luminari S and Jiménez-Ubieto A and Chong G and Tucker D and Ambati S and Lin C and Mohamed H and Brouwer-Visser J and Otele CA and Antico G and Villasboas JC},
  year = {2026},
  journal = {HemaSphere},
  doi = {10.1002/hem3.70300},
  url = {https://doi.org/10.1002/hem3.70300}
}

RIS

TY  - JOUR
TI  - Dynamics of complete responses (CRs) in patients with relapsed or refractory follicular lymphoma (R/R FL) treated with odronextamab in the ELM-2 study.
AU  - Luminari S
AU  - Jiménez-Ubieto A
AU  - Chong G
AU  - Tucker D
AU  - Ambati S
AU  - Lin C
AU  - Mohamed H
AU  - Brouwer-Visser J
AU  - Otele CA
AU  - Antico G
AU  - Villasboas JC
PY  - 2026
JO  - HemaSphere
DO  - 10.1002/hem3.70300
UR  - https://doi.org/10.1002/hem3.70300
ER  - 

APA

S, L., A, J., G, C., D, T., S, A., C, L., H, M., J, B., CA, O., G, A., & JC, V. (2026). Dynamics of complete responses (CRs) in patients with relapsed or refractory follicular lymphoma (R/R FL) treated with odronextamab in the ELM-2 study.. HemaSphere. https://doi.org/10.1002/hem3.70300

Source records